Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-172
Closed -$13K 1071
2026
Q1
$13K Hold
172
0.01% 455
2025
Q4
$12.8K Hold
172
0.01% 442
2025
Q3
$11.6K Sell
172
-2
-1% -$133 0.01% 460
2025
Q2
$11.3K Sell
174
-301
-63% -$18K 0.01% 464
2025
Q1
$29.3K Buy
475
+110
+30% +$7.29K 0.02% 331
2024
Q4
$26.3K Buy
365
+21
+6% +$1.64K 0.02% 345
2024
Q3
$28K Buy
344
+20
+6% +$1.6K 0.02% 346
2024
Q2
$24.1K Buy
324
+16
+5% +$1.2K 0.02% 354
2024
Q1
$24K Hold
308
0.02% 357
2023
Q4
$22K Buy
+308
New +$21.4K 0.02% 359

Other funds holding HOLX

Bruce G. Allen Investments's HOLX Position: Q2 2026 in Review

Bruce G. Allen Investments sold out of Hologic (HOLX) in Q2 2026, closing a stake of 172 shares — an estimated $13K sold.

Bruce G. Allen Investments first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $29.3K in Q1 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Bruce G. Allen Investments reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Bruce G. Allen Investments sold 172 Hologic shares in Q2 2026, an estimated $13K.
  • Bruce G. Allen Investments first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Bruce G. Allen Investments's Hologic position peaked at $29.3K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.